Navigation Links
NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research
Date:10/10/2007

al or public health practice.

  • University of Pennsylvanias Penn Center for ELSI Research
    Reed Pyeritz, M.D., Ph.D., $5.4 million

This center will concentrate on the ethical, legal, and social factors associated with genetic technologies, such as genetic testing, with the potential to generate uncertainty and confusion among patients, relatives, doctors and health insurers. The overall goal of the Penn Center for ELSI Research is to develop tools that will help educate consumers, professionals, policy makers and insurers understand and cope with the certainty or uncertainty of results from genetic technologies.

Team members will conduct original research to explore issues related to uncertainty, including an historical analysis of the ethical, legal, and social consequences of prenatal testing; an assessment of patient and provider perceptions of the barriers and utility of using a preventive genetic test to identify the likelihood of future disease susceptibility; and an evaluation of the long-term psychological, social, and medical effects of genetic testing and counseling for breast cancer on African American women and their families.


'/>"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI expands effort to revolutionize sequencing technologies
4. NHGRI announces new sequencing targets
5. NHGRI announces latest sequencing targets
6. NHGRI aims to make DNA sequencing faster, more cost effective
7. W.M. Keck Foundation funds study of friendly microbes
8. WHO suspends Marburg work, appeals for new funds
9. Grand Challenges in Global Health initiative funds Yale project
10. European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics
11. Federal grant funds research on novel HIV therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids 2Canna can: Ornamental eliminates pollutants from stormwater runoff 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 1Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 2Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 3Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 4
Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4